COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 864: Articles 8631-8640  | Next

Insights on Telemedicine Use by Physiatrists Before, During, and Beyond the COVID-19 Pandemic
Sobrepera, M. J., Weseloh, A., Chaudhri, D., Johnson, M. J.
10.1101/2022.02.19.22270722 — Posted: 2022-02-21
COVID-19 Surveillance in the Biobank at the Colorado Center for Personalized Medicine
Johnson, R. K., Marker, K. M., Mayer, D., Shortt, J., Kao, D., Barnes, K. C., Lowery, J. T., Gignoux, C. R.
10.1101/2022.02.15.22271018 — Posted: 2022-02-21
Closing the health inequity gap during the pandemic: COVID-19 mortality among racial and ethnic groups in Connecticut, March 2020 to December 2021
Schultes, O., Lind, M. L., Brockmeyer, J., Sosensky, P., Cummings, D. A. T., Ko, A. I.
10.1101/2022.02.18.22270820 — Posted: 2022-02-21
Neural Dysregulation in Post-Covid Fatigue
Baker, A. M., Maffitt, N. J., Del Vecchio, A., McKeating, K. M., Baker, M. R., Baker, S. N., Soteropoulos, D. S.
10.1101/2022.02.18.22271040 — Posted: 2022-02-21
Post-COVID-19 tele-survey for persistent symptoms in a single center hospital cohort in India along with a parallel country-wide web-survey
Chaudhuri, K., Sarkar, J., Das, T., Paul, S. R., Basu, R., Gangopadhyay, S., Gangopadhyay, D., Manna, A., Haldar, A., Ray, Y., Banerjee, S., Ganguly, D.
10.1101/2022.02.20.22271119 — Posted: 2022-02-21
Anti-SARS-CoV-2 IgG antibodies after recovery from COVID-19 or vaccination in Libyan population: comparison of four vaccines
Ebrahim, F., Tabal, S., Lamami, Y., Alhudiri, I. M., El Meshri, S. E., Al Dwigen, S. M., Arfa, R., Alboeshi, A., Alemam, H. A., Abuhtna, F., Altarhouni, R. S., Milad, M. B., Elgriw, N., Ruaua, M. A., ABUSREWIL, Z. S., Harroush, W., Jallul, M., Ali, F. S., Eltaib, F. I., Elzagheid, A.
10.1101/2022.02.18.22271130 — Posted: 2022-02-21
The level of liver and renal function biomarker abnormalities among hospitalized COVID-19 patients in Ethiopia
Tsegay, Y., Bitew, M., Atlaw, A., Aragaw, M., Workneh, T., Gemechu, M., Berhane, N.
10.1101/2022.02.15.22271010 — Posted: 2022-02-19
Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study.
Flacco, M. E., Soldato, G., Acuti Martellucci, C., Di Martino, G., Carota, R., Caponetti, A., Manzoli, L.
10.1101/2022.02.19.22271221 — Posted: 2022-02-19
Evolutionary Trajectories of SARS-CoV-2 Alpha and Delta Variants in White-Tailed Deer in Pennsylvania
Marques, A. D., Sherrill-Mix, S., Everett, J., Adhikari, H., Reddy, S., Ellis, J. C., Zeliff, H., Greening, S. S., Cannuscio, C. C., Strelau, K. M., Collman, R. G., Kelly, B. J., Rodino, K. G., Bushman, F. D., Gagne, R. B., Anis, E.
10.1101/2022.02.17.22270679 — Posted: 2022-02-19
Host and microbiome features of secondary infections in lethal covid-19
Zacharias, M., Kashofer, K., Wurm, P., Regitnig, P., Schuette, M., Neger, M., Ehmann, S., Marsh, L. M., Kwapiszewska, G., Loibner, M., Birnhuber, A., Leitner, E., Thueringer, A., Winter, E., Sauer, S., Pollheimer, M. J., Vagena, F. R., Lackner, C., Jelusic, B., Ogilvie, L., Durdevic, M., Timmermann, B., Lehrach, H., Zatloukal, K., Gorkiewicz, G.
10.1101/2022.02.18.22270995 — Posted: 2022-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).